Rallybio Corporation
Rallybio Corporation (RLYB) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
rlyb · stock forecast · 8 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 8 Wall Street analysts in the past 3 months
Buy
8 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $15.91
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $16.66 | ↑ 4.73% |
1-day model range: $16.53–$16.79. Peak: $16.79 (+4.73%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · RLYB · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-04-15 | Jones Trading | Downgrade ↓ | Buy→Hold |
| 2025-04-09 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2025-03-17 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-12-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-08 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-10-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-10-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Rallybio Corporation (RLYB) stock. Of the recent 45 rating actions, 0 were upgrades and 4 were downgrades. 8 analysts currently cover RLYB.
Analyst Recommendation Trends
RLYB analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1M
↓ 99.2% YoY
Revenue Next Year
$0M
↓ 88.6% YoY
EPS This Year
$-1.80
EPS Next Year
$-5.52
↑ 206.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast RLYB EPS of $-1.80 for the current fiscal year, based on estimates from 1 analysts. The RLYB revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The RLYB stock forecast is supported by two independent data sources: analyst consensus ratings from 8 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus RLYB price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The RLYB short-term stock prediction for tomorrow is $16.66 (+4.73%).
Rallybio Corporation trades on NASDAQ under the ticker RLYB. The RLYB stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.
Frequently asked questions
RLYB forecast · 8 questionsAccording to 8 Wall Street analysts, the average 12-month RLYB price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $15.91.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.